Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2022-09-30 00:00:00 ET · period of report 2022-09-28 · accession 0001493152-22-027279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | 2022-09-28 | ABEO | Seshadri Vishwas | CEO, Dir | A - Grant | $0.00 | +155.2K | 165.9K | +1,445% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-28 | A | A | 155,200 | $0.00 | 165,939 | D | — | — | (F1) The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026. |